Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers
Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute
CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
July 2026—The volume of information pathology residents need to know by the end of residency to pass the board exams is extraordinarily large. Certain subspecialties within pathology such as hematopathology can be especially challenging because there are hundreds of CD markers, which can make memorizing them and their associated diseases difficult. Articles have been published on the overload and stress pathology trainees feel.
July 2026—The renewed restriction on remote participation in cytology workflows could have unintended consequences for access to and efficiency and continuity of care, write authors of a Correspondence published online in May in Nature Medicine.
June 2026—Serving on a CAP council or committee is a prestigious and valuable thing to do—but the path to getting there can seem almost impossible to navigate. In recent years, the CAP has changed the process to make it as transparent as possible and to give more people an opportunity to get involved. I’d like to shine a light on committee and council participation to help demystify one of the most important ways you can become more engaged with the CAP.
June 2026—Platelet transfusion in neonate and pediatric patients prevents or stops bleeding. Platelet donor characteristics, such as sex and age, and further processing and storage of platelet units may impact platelet increments, overall transfusion burden, and clinical outcomes in pediatric and neonate transfusion recipients. Platelet collection and processing steps vary across blood centers.
June 2026—Atypical endometriosis is a potential precursor of endometriosis-associated ovarian carcinoma. Despite this, identification of atypical endometriosis (AE) lacks established clinical implications and is not routinely incorporated in histopathological examinations for endometriosis. The authors conducted a study to determine the interobserver variability in AE diagnosis and classify features that may contribute to consistent identification and diagnosis.
June 2026—Studies of genetic variants in autism spectrum disorders have identified copy-number variants and single-nucleotide variants in more than 100 autism spectrum disorder-associated genes. However, much of the genetic and neurobiological bases of such disorders are still unclear. Some of the yet unexplained genetic basis of autism spectrum disorder (ASD) may lie in variants that may be difficult to detect by short-read whole genome sequencing (SR-WGS), such as specific structural variants and tandem repeats.
June 2026
Q. When performing a manual platelet estimate from a sodium citrate tube because of EDTA-induced clumping, do you still multiply the result by 1.1, even if you are not using an analyzer to perform the estimate? Read answer.
Q. How is Helicobacter pylori 13C urea breath testing regulated in clinical laboratories? Read answer.
June 2026—As the scope and scale of information technology available to the pathology laboratory balloons, so too do the number of proposals for lab IT projects, products, and partnerships. And those pitching such proposals can up their odds of success if they avoid using technical jargon, acronyms, and other IT speak when explaining such endeavors to an audience without expertise in those areas, says communications expert Terry Rubin.
June 2026—The blood bank community, state pathology societies, and the CAP and Association for the Advancement of Blood and Biotherapies are working to oppose state bills that mandate directed and autologous blood donations. Most such proposals have failed, but Idaho’s law was enacted on March 16. It will go into effect July 1.
May 2026—The CAP recently reached a record high of over 20,000 members, strengthening its advocacy efforts. Through PathPAC, the CAP engages with federal policymakers to advocate for pathologists and patient care. The CAP also advocates for the pathology community through its involvement with the AMA.
